Non-Current Assets

Other Non-Current Assets

Bristol-Myers Squibb Other Non-Current Assets increased by 6.0% to $6.47B in Q4 2025 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryOther

SignalContext dependent

VolatilityStable

First reportedQ4 2025

Last reportedQ1 2026

How to read this metric

Significant changes may indicate shifts in accounting estimates, tax positions, or non-core asset holdings.

Detailed definition

This category includes long-term assets that do not fit into specific classifications like PP&E or intangibles, such as...

Peer comparison

Standard line item in most balance sheets, often labeled 'Other non-current assets'.

Metric ID: non_current_assets_other_assets_noncurrent

Historical Data

2 periods

	Q4 '24	Q4 '25
Value	$6.11B	$6.47B
QoQ Change	—	+6.0%
YoY Change	—	+6.0%

Range$6.11B – $6.47B

Avg YoY Growth+6.0%

Median YoY Growth+6.0%

Other Non-Current Assets at Other Companies

JNJJNJ View metric

BSXBSX View metric

CVSCVS View metric

AVGOAVGO View metric

SYKSYK View metric

Frequently Asked Questions

What is Bristol-Myers Squibb's other non-current assets?: Bristol-Myers Squibb (BMY) reported other non-current assets of $6.47B in Q4 2025.
What does other non-current assets mean?: Miscellaneous long-term assets that do not fall into standard categories.